Kyme Pierre 4

What Happened

• Kyme Pierre, Chief Business Officer of Armata Pharmaceuticals (ARMP), had 1,030 shares withheld by the company to satisfy tax withholding related to the net settlement of restricted stock units. The shares were valued at $10.54 each, for a total of $10,856 (transaction code F — tax withholding/disposition).

Key Details

• Transaction date: 2026-03-14; Filing date: 2026-03-17 (no late-filing indicator shown in the Form 4).
• Shares involved: 1,030; Price per share: $10.54; Total value: $10,856.
• Transaction code: F — shares withheld to satisfy tax withholding obligations on net-settled RSUs.
• Footnote: The withheld shares were remitted by the company to cover income tax and withholding obligations in connection with net settlement of restricted stock units.
• Shares owned after the transaction: not specified in the provided filing details.

Context

• This was not an open-market sale or a purchase but a routine tax-withholding/net settlement of RSUs (effectively a cashless settlement). Such withholding transactions are common and do not necessarily indicate insider sentiment about the stock. Purchases and open-market sales usually carry more interpretive weight for investors.